Pages that link to "Q22242719"

The following pages link to Antibiotics and probiotics in inflammatory bowel disease: why, when, and how (Q22242719):

Displaying 23 items.

• Use of antibiotics in the treatment of Crohn's disease (Q22241216) (← links)
• Part 2: Treatments for Chronic Gastrointestinal Disease and Gut Dysbiosis (Q26771942) (← links)
• MyD88 mediates the protective effects of probiotics against the arteriolar thrombosis and leukocyte recruitment associated with experimental colitis (Q27314871) (← links)
• Mechanisms of intestinal inflammation and development of associated cancers: lessons learned from mouse models (Q33886458) (← links)
• Alterations in the gut microbiome of children with severe ulcerative colitis (Q34101549) (← links)
• Recent advances in understanding enteric pathogenic Escherichia coli. (Q34375210) (← links)
• Meta-analysis of ciprofloxacin in treatment of Crohn's disease (Q34607551) (← links)
• Does evidence exist to include dietary therapy in the treatment of Crohn's disease? (Q34618308) (← links)
• Can inflammatory bowel disease be permanently treated with short-term interventions on the microbiome? (Q35558415) (← links)
• Clostridium difficile Infection: A Rarity in Patients Receiving Chronic Antibiotic Treatment for Crohn's Disease (Q36941569) (← links)
• Review article: remission rates achievable by current therapies for inflammatory bowel disease (Q37842605) (← links)
• Two faces of microbiota in inflammatory and autoimmune diseases: triggers and drugs (Q38055197) (← links)
• Meta-analysis of broad-spectrum antibiotic therapy in patients with active inflammatory bowel disease (Q38066200) (← links)
• The role of antimicrobials in Crohn's disease (Q38085068) (← links)
• Mouse models of intestinal inflammation and cancer (Q38867429) (← links)
• Analysis of Escherichia coli Isolated from Patients Affected by Crohn’s Disease (Q39533375) (← links)
• Extraintestinal pathogenic Escherichia coli are associated with intestinal inflammation in patients with ulcerative colitis (Q40522367) (← links)
• Rifaximin and Crohn's disease: a new solution to an old problem? (Q43162343) (← links)
• Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition (Q51614351) (← links)
• NMR-based metabolomics in human disease diagnosis: applications, limitations, and recommendations (Q57016043) (← links)
• Pathobionts Associated with Inflammatory Bowel Disease (Q63727118) (← links)
• A NOD for autophagy (Q82433665) (← links)
• Probiotics and the immune response to vaccines (Q84390507) (← links)